Overview

Relative Bioavailability of Epinastine Syrup Compared to Tablets in Healthy Volunteers

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To assess the bioequivalence of two galenic formulations for epinastine (Flurinol®): syrup and 20 mg tablets
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Epinastine